Infliximab in the treatment of Crohn’s disease

The recent introduction of infliximab, a chimeric monoclonal antibody against tumor necrosis factor-α, has greatly modified the treatment of Crohn’s disease (CD). Data from the literature show encouraging results after intravenous infusion both for closure of intestinal or perianal fistulas and for...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Poggioli, Gilberto, Laureti, Silvio, Campieri, Massimo, Pierangeli, Filippo, Gionchetti, Paolo, Ugolini, Federica, Gentilini, Lorenzo, Bazzi, Piero, Rizzello, Fernando, Coscia, Maurizio
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2007
Assuntos:
Reviews
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1936311/
https://ncbi.nlm.nih.gov/pubmed/18360638
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares